Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT04349267
Title Study of BMS-986315 Alone and in Combination With Nivolumab or Cetuximab in Participants With Advanced Solid Tumors
Recruitment Terminated
Gender both
Phase Phase Ib/II
Variant Requirements No
Sponsors Bristol-Myers Squibb
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA | CAN

Facility Status City State Zip Country Details
Local Institution - 0028 Sioux Falls South Dakota 57104 United States Details
Local Institution - 0001 Germantown Tennessee 38138 United States Details
Local Institution - 0014 Edmonton Alberta T6X 1E8 Canada Details
Local Institution - 0011 Vancouver British Columbia V5Z 4E6 Canada Details
Local Institution - 0004 Toronto Ontario M5G 2M9 Canada Details
Local Institution - 0005 Montreal Quebec H2X 3E4 Canada Details
Local Institution - 0013 Ottawa K1H 8L6 Canada Details
Local Institution Mexico city Distrito Federal 06100 Mexico Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field